Viewing nowCombinationTelmisartan/Amlodipine Plus Tablets 40/5/10 Milligrams
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myeong Mun Pharmaceutical Co., Ltd.

MFDS item code 201904522 · Approved 2019.07.03 · Insurance code 649807460
Treatment of hypertension, improvement of dyslipidemia, and suppression of atherosclerosis progression and cardiovascular disease risk
This medicine is used in patients with essential hypertension who do not adequately control their blood pressure with telmisartan and amlodipine combination, and rosuvastatin should also be administered. Rosuvastatin is used when diet and exercise therapies do not adequately control primary hypercholesterolemia or mixed dyslipidemia, and it lowers cholesterol levels in patients with hypercholesterolemia to delay the progression of atherosclerosis. Moreover, it is also expected to reduce the risk of stroke, myocardial infarction, and vascular revascularization procedures in middle-aged individuals at high risk for cardiovascular diseases. This medication is used to effectively manage cardiovascular health by assisting with blood pressure control and improving blood lipids.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. Patients taking telmisartan/amlodipine combination therapy together with rosuvastatin as a single agent may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients in this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, rosuvastatin Cmax increased by approximately 2.1-fold and AUC by approximately 1.2-fold in the presence of telmisartan/amlodipine. Therefore, when administering this medicine, assess the potential risk resulting from the increase in rosuvastatin Cmax and monitor patients closely.
This drug may cause serious harm to the fetus and newborn during pregnancy; therefore, if pregnancy is confirmed, use should be discontinued immediately. This drug should not be used if there is an allergy to its ingredients or similar drugs. It is safer not to administer this drug to patients with severely impaired liver or kidney function, certain heart diseases, or certain muscular disorders. Special caution should be exercised when using this drug in elderly patients, patients with very low blood pressure, or those with high serum potassium levels. If symptoms such as muscle pain, muscle weakness, or related symptoms occur, consult a doctor immediately, and if necessary, serum muscle enzyme levels should be checked, and the medication may need to be discontinued if abnormalities are found. This drug may affect liver function; therefore, regular liver function tests should be carried out before and during treatment. Since drug interactions may occur when taken with other medications, it is crucial to inform the doctor or pharmacist if other medications are being taken. This drug is generally not used during breastfeeding; if it must be taken, breastfeeding should be stopped. Safety and efficacy in children have not been sufficiently verified, so its use is not recommended. In case of overdose, symptoms may include hypotension, dizziness, and arrhythmia; necessary medical attention should be sought immediately.
Peripheral edema, dyspepsia, frequent bowel movements, diabetes, dizziness, dry vesicular sounds, urticaria, unstable angina, onychomycosis, lumbar spinal stenosis, otorrhea, vertigo, chronic gastritis, hiatal hernia, musculoskeletal pain, neck pain, nasopharyngitis, upper abdominal discomfort, upper abdominal pain, positional vertigo, dysuria, rhinitis, oral pharyngeal discomfort, pulmonary disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, polyuria, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory infection, low back pain, sinusitis, diarrhea, pharyngitis, influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, sensory disturbance, involuntary muscle contraction, sensory loss, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, anxiety, depression, neuralgia, infection, fungal infection, abscess, otitis media, asthma, bronchitis, rhinitis, dyspnea, epistaxis, dermatitis, rash, eczema, pruritus, frequent urination, cystitis, cerebrovascular disease, visual disturbances, conjunctivitis, ear pain, vascular edema, fever, leg pain, malaise, headache, dizziness, asthenia, cough, nausea, fatigue, weakness, edema, facial edema, lower limb edema, vascular edema, pruritus, hypersensitivity reaction, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, elevated blood pressure, worsening hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, dyspepsia, diarrhea, urinary tract infection, erectile dysfunction, muscle cramps, myalgia, bradycardia, eosinophilia, thrombocytopenia, increased uric acid, liver function abnormalities, liver disease, acute renal failure, anemia, CPK elevation, anaphylactic reaction, tendon pain, rhabdomyolysis, vascular edema, headache, edema, dizziness, flushing, palpitations, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, orthostatic hypotension, vasculitis, peripheral neuropathy, tremors, loss of appetite, dysphagia, pancreatitis, gingival hyperplasia, allergic reaction, burning sensation, malaise, stiffness, weight gain, weight loss, arthralgia, osteoarthritis, muscle cramps, sexual dysfunction, insomnia, neuralgia, abnormal dreams, depersonalization, dyspnea, epistaxis, vascular edema, erythema multiforme, rash, erythematous rash, papular rash, frequent urination, urination disorders, nocturia, dry mouth, increased perspiration, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, dizziness, ALT elevation, chest pain, cough, myalgia, CK elevation, constipation, AST elevation, asthenia, arthralgia, fatigue, numbness, sensory disturbances, chest discomfort, nausea, abdominal pain, diarrhea, loss of appetite, abdominal bloating, abnormal liver function tests, syncope, systemic pain, muscle cramps, gout, erectile dysfunction, elevated serum potassium, increased creatinine, anemia, thrombocytopenia, elevated serum creatinine, hypotension, tachycardia, bradycardia, acute renal failure, excessive peripheral vasodilation, reflex tachycardia, systemic hypotension, noncardiogenic pulmonary edema, jaundice, elevated liver enzyme levels, leukopenia, confusion, exfoliative dermatitis, Stevens-Johnson syndrome, photosensitivity reaction, toxic epidermal necrolysis, gynecomastia, interstitial lung disease, memory loss, peripheral neuropathy, thrombocytopenia, liver failure, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, severe skin adverse reactions, severe muscle weakness, ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light and should be stored in a light-resistant container. It is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness for a longer period.
Oval-shaped bilayer tablet consisting of a white layer and a light blue layer
30 tablets/box [10 tablets/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myeong Mun Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samchundang Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.